Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
US5662907A · kind A · utility
71Cited by
3References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 1994 |
| Grant date | Sep 2, 1997 |
| Priority date | — |
| Expiry date | Jan 25, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for treating cancer. The invention provides peptides based on a 9 residue epitope derived from the product of the tumor-associated gene MAGE-3. The peptide induces CTL that kill melanoma and other tumor cells lines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.